Jan 19 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* DECIDED TODAY TO CALL AN EXTRAORDINARY GENERAL MEETING TO
TAKE A
DECISION ON A CASH DIVIDEND OF MAXIMUM AMOUNT OF CAPITAL
AVAILABLE AND TO DECIDE THAT COMPANY IS TO BE LIQUIDATED
* ASSESSMENT IS BASED ON A THOROUGH ANALYSIS OF ISOFOL'S
FUTURE
OPPORTUNITIES AFTER NEGATIVE OUTCOME OF COMPANY'S PHASE III
STUDY (AGENT)ANDAIMS TO ENSURE THAT AS LARGE A PART OF COMPANY'S
REMAINING ASSETS AS POSSIBLE BENEFIT SHAREHOLDERS
* ASSUMING THAT EXTRAORDINARY GENERAL MEETING DECIDES IN
ACCORDANCE WITH BOARD'S PROPOSAL, BOARD WILL APPLY FOR COMPANY'S
DELISTING FROM NASDAQ STOCKHOLM
Source text for Eikon: ID:nWkr8Ns31y
Further company coverage: ISOFOL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))